RxDoctor Payments Data

Dennis Wales, MD

Family Medicine · Durango, CONPI 1376650408

Payments from drug & device makers

$322in general payments, 2019–2025

Across 11 payments — averaging $29.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Gilead$100
  • BETA Bionics, Inc.$50
  • Exact Sciences$45
  • Abbott$21
  • Philips North America LLC$20
  • Sumitomo Pharma America, Inc.$19
  • plus $67 from 4 others

What the payments were for

  • Food & beverage$322100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$322 in reported general payments places this provider in the 65th percentile of 2,079 family medicine providers in Colorado.

See all family medicine providers in Colorado

Medicare billing

Part B allowed, 2024
$104,508
Medicare patients
487
Services billed
1,536

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban69$75,071
XareltoRivaroxaban54$65,523
MounjaroTirzepatide45$48,107
TrulicityDulaglutide40$39,473
JardianceEmpagliflozin22$36,407
OzempicSemaglutide18$23,742
FarxigaDapagliflozin Propanediol11$15,360
Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/718$14,541
Fluticasone-SalmeterolFluticasone Propion/Salmeterol31$9,191
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog12$7,167
Doxepin Hcl24$5,622
QuviviqDaridorexant Hcl12$5,438
JanuviaSitagliptin Phosphate11$4,820
Atorvastatin Calcium495$4,760
Levothyroxine Sodium377$3,982

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
MerckJanuvia$18$4,82011 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 2,079 family medicine providers in Colorado.

Other family medicine in Durango

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →